Article Cited by others

RESEARCH

The role of c-kit and imatinib mesylate in uveal melanoma

Pereira Patricia Rusa, Odashiro Alexandre Nakao, Marshall Jean Claude, Correa Zelia Maria, Belfort Jr Rubens, Burnier Jr Miguel N

Year : 2005| Volume: 4| Issue : 1 | Page no: 19-19

   This article has been cited by
 
1 Mechanisms of resistance to imatinib mesylate in KIT-positive metastatic uveal melanoma
Armelle Calipel,Solange Landreville,Arnaud Fouchardière,Frédéric Mascarelli,Michel Rivoire,Nicolas Penel,Frédéric Mouriaux
Clinical & Experimental Metastasis. 2014;
[Pubmed]  [Google Scholar] [DOI]
2 The effect of imatinib mesylate on the proliferation, invasive ability, and radiosensitivity of retinoblastoma cell lines
L R de Moura,J-C Marshall,S Di Cesare,B F Fernandes,E Antecka,M N Burnier
Eye. 2013; 27(1): 92
[Pubmed]  [Google Scholar] [DOI]
3 Ocular melanoma : whatʼs new?
Serge Leyvraz, Ulrich Keilholz
Current Opinion in Oncology. 2012; 24(2): 162
[HTML Full text]  [Google Scholar] [DOI]
4 KIT mutations in ocular melanoma: frequency and anatomic distribution
Michelle L Wallander, Lester J Layfield, Lyska L Emerson, Nick Mamalis, Don Davis, Sheryl R Tripp, Joseph A Holden
Modern Pathology. 2011;
[HTML Full text]  [Google Scholar] [DOI]
5 A phase 2 trial of dasatinib in advanced melanoma
Harriet M. Kluger, Arkadiuz Z. Dudek, Carrie McCann, Jean Ritacco, Nadine Southard, Lucia B. Jilaveanu, Annette Molinaro, Mario Sznol
Cancer. 2010; : n/a
[HTML Full text]  [Google Scholar] [DOI]
6 c-KIT in uveal melanoma: Big fish or red herring?
Daniels, A.B., Abramson, D.H.
Archives of Ophthalmology. 2009; 127(5): 695-697
[Pubmed]  [Google Scholar]
7 O-Mel-Inib: A Cancéro-pôle Nord-Ouest multicenter phase II trial of high-dose Imatinib mesylate in metastatic uveal melanoma
Penel, N., Delcambre, C., Durando, X., Clisant, S., Hebbar, M., Negrier, S., Fournier, C., (...), Mouriaux, F.
Investigational New Drugs. 2008; 26(6): 561-565
[Pubmed]  [Google Scholar]
8 Malignant melanoma in the 21st century: The emerging molecular landscape
Sekulic, A., Haluska Jr., P., Miller, A.J., De Lamo, J.G., Ejadi, S., Pulido, J.S., Salomao, D.R., (...), Markovic, S.N.
Mayo Clinic Proceedings. 2008; 83(7): 825-846
[Pubmed]  [Google Scholar]
9 Targeted therapy for uveal melanoma
Triozzi, P.L., Eng, C., Singh, A.D.
Cancer Treatment Reviews. 2008; 34(3): 247-258
[Pubmed]  [Google Scholar]
10 Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas
Satzger, I., Schaefer, T., Kuettler, U., Broecker, V., Voelker, B., Ostertag, H., Kapp, A., Gutzmer, R.
British Journal of Cancer. 2008; 99(12): 2065-2069
[Pubmed]  [Google Scholar]
11 Differential effects of imatinib mesylate against uveal melanoma in vitro and in vivo
Triozzi, P.L., Aldrich, W., Dombos, C.
Melanoma Research. 2008; 18(6): 420-430
[Pubmed]  [Google Scholar]
12 Differential effects of imatinib mesylate against uveal melanoma in vitro and in vivo
Pierre L. Triozzi,Wayne Aldrich,Christopher Dombos
Melanoma Research. 2008; 18(6): 420
[Pubmed]  [Google Scholar] [DOI]
13 Targeted therapy for uveal melanoma
Pierre L. Triozzi,Charis Eng,Arun D. Singh
Cancer Treatment Reviews. 2008; 34(3): 247
[Pubmed]  [Google Scholar] [DOI]
14 Malignant Melanoma in the 21st Century: The Emerging Molecular Landscape
Aleksandar Sekulic,Paul Haluska,Arlo J. Miller,Josep Genebriera De Lamo,Samuel Ejadi,Jose S. Pulido,Diva R. Salomao,Erik C. Thorland,Richard G. Vile,David L. Swanson,Barbara A. Pockaj,Susan D. Laman,Mark R. Pittelkow,Svetomir N. Markovic
Mayo Clinic Proceedings. 2008; 83(7): 825
[Pubmed]  [Google Scholar] [DOI]
15 Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas
I Satzger,T Schaefer,U Kuettler,V Broecker,B Voelker,H Ostertag,A Kapp,R Gutzmer
British Journal of Cancer. 2008; 99(12): 2065
[Pubmed]  [Google Scholar] [DOI]
16 Caspase-8-mediated apoptosis in human RPE cells
Yang, P., Peairs, J.J., Tano, R., Zhang, N., Tyrell, J., Jaffe, G.J.
Investigative Ophthalmology and Visual Science. 2007; 48(7): 3341-3349
[Pubmed]  [Google Scholar]
17 Immunohistochemical expression of COX-2 and c-kit in metastatic uveal melanoma
Frota, A.C.D.A., Odashiro, A.N., Pereira, P.R., Fernandes, B.F., Godeiro, K.D., Souza Filho, J.P., Burnier Jr., M.N.
Canadian Journal of Ophthalmology. 2007; 42(1): 145-146
[Pubmed]  [Google Scholar]
18 Proteomics in uveal melanoma research: opportunities and challenges in biomarker discovery
María Pardo,Raymond A Dwek,Nicole Zitzmann
Expert Review of Proteomics. 2007; 4(2): 273
[Pubmed]  [Google Scholar] [DOI]
19 Evaluation of gene expression related to hepatic cell maturation and differentiation in a chemically induced mouse hepatoblastoma cell line
Tetsuya Sakairi,Miyoko Okada,Itsuko Ikeda,Hiroyuki Utsumi,Shin Kohge,Jiro Sugimoto,Fumiko Sano,Shiro Takagi
Experimental and Molecular Pathology. 2007; 83(3): 419
[Pubmed]  [Google Scholar] [DOI]
20 Evaluation of gene expression related to hepatic cell maturation and differentiation in a chemically induced mouse hepatoblastoma cell line
Sakairi, T., Okada, M., Ikeda, I., Utsumi, H., Kohge, S., Sugimoto, J., Sano, F., Takagi, S.
Experimental and Molecular Pathology. 2007; 83(3): 419-427
[Pubmed]  [Google Scholar]
21 Expression of C-kit in retinoblastoma: A potential therapeutic target
Barry, R.J., De Moura, L.R., Marshall, J.-C., Fernandes, B.F., Orellana, M.E., Antecka, E., Martins, C., Burnier, M.N.
British Journal of Ophthalmology. 2007; 91(11): 1532-1536
[Pubmed]  [Google Scholar]
22 Proteomics in uveal melanoma research: Opportunities and challenges in biomarker discovery
Pardo, M., Dwek, R.A., Zitzmann, N.
Expert Review of Proteomics. 2007; 4(2): 273-286
[Pubmed]  [Google Scholar]
23 Expression of EpCAM in uveal melanoma
Odashiro, D.N., Odashiro, A.N., Pereira, P.R., Godeiro, K., Antecka, E., Di Cesare, S., Burnier Jr., M.N.
Cancer Cell International. 2006; 6(Art 26)
[Pubmed]  [Google Scholar]
24 The effect of imatinib mesylate (Glivec) on human tumor-derived cells
Knight, L.A., Nicolantonio, F.D., Whitehouse, P.A., Mercer, S.J., Sharma, S., Glaysher, S., Hungerford, J.L., (...), Cree, I.A.
Anti-Cancer Drugs. 2006; 17(6): 649-655
[Pubmed]  [Google Scholar]
25 The effect of imatinib mesylate (Glivec) on human tumor-derived cells
Louise A. Knight,Federica Di Nicolantonio,Pauline A. Whitehouse,Stuart J. Mercer,Sanjay Sharma,Sharon Glaysher,John L. Hungerford,Jeremy Hurren,Alan Lamont,Ian A. Cree
Anti-Cancer Drugs. 2006; 17(6): 649
[Pubmed]  [Google Scholar] [DOI]

 

Read this article